Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women Study.
作者信息
Banks Emily, Reeves Gillian, Beral Valerie, Bull Diana, Crossley Barbara, Simmonds Moya, Hilton Elizabeth, Bailey Stephen, Barrett Nigel, Briers Peter, English Ruth, Jackson Alan, Kutt Elizabeth, Lavelle Janet, Rockall Linda, Wallis Matthew G, Wilson Mary, Patnick Julietta
机构信息
Cancer Research UK Epidemiology Unit, Gibson Building, Radcliffe Infirmary, Oxford OX2 6HE.
出版信息
BMJ. 2004 May 29;328(7451):1291-2. doi: 10.1136/bmj.328.7451.1291.
Abstract
摘要
相似文献
1
Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women Study.
BMJ. 2004 May 29;328(7451):1291-2. doi: 10.1136/bmj.328.7451.1291.
2
Breast screening: the use of consensus opinion for all recalls.
Breast. 2004 Jun;13(3):184-7. doi: 10.1016/j.breast.2003.12.004.
3
Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect.
Breast Cancer Res. 2006;8(1):R8. doi: 10.1186/bcr1364. Epub 2005 Dec 23.
4
Hormone replacement therapy and mammographic screening.
J Br Menopause Soc. 2004 Jun;10(2):75, 80. doi: 10.1258/136218004774202391.
5
Influence of hormone replacement therapy on the accuracy of screening mammography.
Breast J. 2006 Mar-Apr;12(2):154-8. doi: 10.1111/j.1075-122X.2006.00224.x.
6
Breast screening in women aged 40-49 years: what next?
Lancet. 1999 Jun 5;353(9168):1896-7. doi: 10.1016/S0140-6736(99)90074-0.
7
Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.
J Natl Cancer Inst. 2005 May 18;97(10):748-54. doi: 10.1093/jnci/dji131.
8
[Breast cancer, mammography screening and hormone therapy].
Ugeskr Laeger. 2004 Aug 16;166(34):2915.
9
[Breast cancer, mammography screening and hormone therapy].
Ugeskr Laeger. 2004 Aug 30;166(36):3113-4.
10
Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
J Epidemiol Community Health. 2006 Apr;60(4):316-21. doi: 10.1136/jech.2005.042119.
引用本文的文献
1
"I Am Hot, Irritable and Feeling Low; What Alternatives do I have Besides Hormone Replacement Therapy?".
Malays Fam Physician. 2010 Dec 31;5(3):126-9. eCollection 2010.
2
False-positive results in the randomized controlled trial of mammographic screening from age 40 ("Age" trial).
Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2758-64. doi: 10.1158/1055-9965.EPI-10-0623. Epub 2010 Sep 13.
3
Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect.
Breast Cancer Res. 2006;8(1):R8. doi: 10.1186/bcr1364. Epub 2005 Dec 23.
4
Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study.
BMJ. 2004 Aug 28;329(7464):477. doi: 10.1136/bmj.329.7464.477.
本文引用的文献
1
Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.
BJOG. 2002 Dec;109(12):1319-30. doi: 10.1016/s1470-0328(02)02914-2.
2
Impact of false-positive mammography on subsequent screening attendance and risk of cancer.
Breast Cancer Res. 2002;4(5):R11. doi: 10.1186/bcr455. Epub 2002 Jul 17.
3
Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review.
J Med Screen. 2001;8(1):29-34. doi: 10.1136/jms.8.1.29.
4
The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group.
Breast Cancer Res. 1999;1(1):73-80. doi: 10.1186/bcr16. Epub 1999 Aug 19.
Zotero 插件